Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6015542

Title:Radioimmunotherapy of lymphoma using anti-CD20 antibodies
Inventors:Kaminski, Mark S.; Ann Arbor, MI, USA
Butchko, Gregory M.; Miami Lakes, FL, USA
Glenn, Stephan D.; Davie, FL, USA
Wahl, Richard L.; Ann Arbor, MI, USA
Summary:Described herein are novel compositions containing radiolabeled anti-CD20 monoclonal antibodies. The invention relates specifically to the treatment of B-cell lymphoma by such compositions, via the administration to a patient of both unlabeled antibodies and antibodies labeled with a radioisotope. Claims of the invention include advantageous tumor responses without severe myelosuppression, which are obtainable by this method in radiometric dosage ranges that do not require hematopoietic stem cell replacement as an adjunct therapy.
Abstract:Methods for the treatment of lymphoma by administration of a B cell-specific antibody are described. The invention encompasses providing to a patient both unlabeled antibodies and antibodies labeled with a radioisotope. A principal advantage of the method is that tumor responses can be obtained in a radiometric dose range that does not require hematopoietic stem cell replacement as an adjunct therapy also described is a composition useful in the treatment of lymphoma.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6015542
Application Number:US1996000711527
Date Filed:10/09/1996
Date Published:18/01/2000
Assignee:Coulter Pharmaceutical, Inc., South San Francisco, CA, USA The Regents of the University of Michigan, Ann Arbor, MI, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/22/2021